Home > Article > Letter from the Editor
Respiratory Tract Disorders
Read Time: 2 mins

Letter from the Editor

Published Online: August 21st 2015 European Respiratory and Pulmonary Diseases, 2015;1(1):13 DOI: //doi.org/10.17925/ERPD.2015.01.01.13
Authors: David Price
Quick Links:
Article Information

Dear Colleague

It is a privilege and a pleasure to welcome you to European Respiratory and Pulmonary Diseases. This new journal is an annual publication that aims to publish unbiased, balanced reviews, case reports, practice guides, theoretical discussions and original research on topics of interest to the respiratory community. Our reviews are written by worldrenowned key opinion leaders from a variety of respiratory disciplines, and aim to make data from primary papers accessible to all healthcare professionals. Our articles are intended to provide practical advice and opinions on how current research findings can help physicians in the everyday clinical setting. We hope that these articles will promote discussion and learning.

All articles undergo a rigorous double-blind peer review, conducted by at least two independent experts in the field to ensure that articles are balanced, unbiased and relevant. All articles are open access, enabling readers to download articles free of charge and allowing widespread dissemination of information. European Respiratory and Pulmonary Diseases is supported by an editorial board consisting of leading experts from Europe from a number of respiratory disciplines. Our touchRESPIRATORY website offers a range of multimedia resources to further facilitate learning.

The journal is of interest to physicians, healthcare professionals and researchers across Europe, providing practical advice relevant to the clinical setting and addressing the most salient developments in the respiratory field. We also offer authors the opportunity to publish multimedia content of their work including podcasts, videos and slides. Of particular interest to the journal are concise reviews on new treatments, drugs and technologies, although short series and original material are also welcome.

We would like to hear from any leading authorities who would like to discuss potential submissions. Articles are independently commissioned by the managing editor. We also welcome industry-sponsored articles that are balanced and relevant. Our journal adheres to the publication guidelines recommended by the International Committee of Medical Journal Editors (ICMJE) (www.icmje.org) and the Good Publication Practice guidelines (www.ismpp.org/gpp2). All authors are asked to disclose personal, commercial, academic and financial interests in the disclosures section, along with any funding, financial support and medical writing assistance relating to the paper. The ‘Instructions to Authors’ information is available for download at www.touchrespiratory .com

We look forward your participation in this new journal, which will surely play an important role in keeping professionals updated on the most relevant advances in the field of respiratory and pulmonary diseases.

Article Information:

David Price has no relevant conflicts of interest to declare. No funding was received in the publication of this article.


David Price, Professor of Primary Care Respiratory Medicine, University of Aberdeen, UK. E: [email protected]

Open Access

This article is published under the Creative Commons Attribution Noncommercial License, which permits any non-commercial use, distribution, adaptation and reproduction provided the original author(s) and source are given appropriate credit.



Further Resources

Share this Article
Related Content In Respiratory Tract Disorders
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar